press center press release

Semi-annual review of OMX Copenhagen 20 Index

Published

Stockholm, June 3, 2010 - The NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) announced today the result of the semi-annual review of the OMX Copenhagen 20 Index (NASDAQ OMX Copenhagen: OMXC20), which will become effective with the market open on Monday, June 21, 2010. As a result of the re-ranking NASDAQ OMX will add Coloplast to the OMXC20 Index and remove Genmab. The OMXC20 Index is the NASDAQ OMX Copenhagen's tradable index. It was introduced July 3, 1989 as an underlying instrument for futures and options. The OMXC20 Index has a base value of 100 and is weighted in terms of free floated market value. The OMX Copenhagen 20 Index constituents effective June 21, 2010 are: A.P. Møller - Mærsk A A.P. Møller - Mærsk B Carlsberg A/S B Coloplast B D/S Norden Danisco Danske Bank DSV FLSmidth & Co. Jyske Bank A/S Lundbeck NKT Holding Nordea Bank AB Novo Nordisk B Novozymes B Sydbank Topdanmark TrygVesta Vestas Wind Systems William Demant Holding About NASDAQ OMX Index Products NASDAQ OMX is a global leader in creating and licensing strategy indexes and is home to the most widely watched indexes in the world. As a premier, full-service provider, NASDAQ OMX is dedicated to designing powerful indexes that are in sync with a continually changing market environment. Utilizing the expanded coverage of our global company, NASDAQ OMX has nearly 1,500 diverse equity, commodity and fixed-income indexes in the U.S., Europe, and throughout world. In addition, our calculation, licensing and marketing support provide the tools to measure and replicate global markets. The NASDAQ OMX Index Group range of services covers the entire business process from index design to calculation and dissemination. For more information about NASDAQ OMX indexes, visit https://indexes.nasdaqomx.com/. About NASDAQ OMX The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit www.nasdaqomxnordic.com. Please follow NASDAQ OMX on Facebook (www.facebook.com/nasdaqomxnorden) and Twitter (www.twitter.com/nasdaqomxnordic). Cautionary Note Regarding Forward-Looking Statements The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements. There can be no assurance that the FSA will give the NASDAQ OMX applicant the authorization and permissions which it seeks. - # - Media Contacts: Carl Norell +46 8 405 66 39 carl.norell@nasdaqomx.com

In This Story

Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more